Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1317P is a pseudogene copy of the U6 small nuclear RNA (snRNA) gene. U6 snRNA itself is a highly conserved small nuclear non-coding RNA involved in the spliceosomal excision of introns from pre-mRNA during mRNA splicing in eukaryotes[1][3]. However, RNU6-1317P is a pseudogene—a non-functional, non-protein-coding genomic sequence that resembles the functional U6 snRNA gene but typically does not produce a functional RNA or protein product[4]. U6 snRNA pseudogenes, such as RNU6-1317P, usually arise through retrotransposition processes facilitated by LINE-1 elements and are often dispersed throughout the genome as non-functional relics[4]. In general, pseudogenes like RNU6-1317P do not possess any known biological activity, are not drug targets, and have no established roles in disease or therapy. Their primary scientific relevance is in studies of genome evolution and retrotransposition dynamics[4]. Key caveat: This gene is not a receptor, enzyme, transporter, or any molecule type typically targeted in therapeutic settings. It lacks functional RNA production and is considered non-functional. Its only relevance is as a marker in genomics rather than in cell biology, pathophysiology, or pharmacology[4]. Summary: RNU6-1317P corresponds to a pseudogene of U6 snRNA, has no known function, is not therapeutically relevant, and should not be considered a canonical target for drugs or biological research beyond studies of pseudogene formation[4].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1317, pseudogene (RNU6-1317P).